Skip to search formSkip to main contentSkip to account menu

hematide

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
As recently reported, dried blood spot (DBS) analysis is an advantageous technique for doping control purposes due to the minimal… 
Highly Cited
2009
Highly Cited
2009
Doping of athletes with recombinant and genetically modified erythropoietins (EPO) is currently detected by isoelectric focusing… 
Review
2009
Review
2009
Hematide™ is an investigational erythropoiesis-stimulating agent (ESA) being evaluated for the treatment of anemia in chronic… 
2008
2008
The pharmacology, toxicokinetics, and safety of HematideTM, a synthetic peptidic erythropoiesis-stimulating agent (ESA), were… 
Review
2008
Review
2008
Nearly two decades ago, recombinant human erythropoietin transformed the management of chronic kidney disease anemia by allowing… 
Review
2008
Review
2008
Hematide is a synthetic peptide-based erythropoiesis-stimulating agent that is being developed by Affymax Inc and Takeda… 
Highly Cited
2006
Highly Cited
2006
Hematide is an investigational pegylated synthetic peptide that stimulates erythropoiesis in animal models and is being developed… 
2004
2004
Hematide™ is a PEGylated synthetic dimeric peptide. Initial peptide sequences were identified by screening a human erythropoietin…